Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-07-09
2010-10-19
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S209000
Reexamination Certificate
active
07816377
ABSTRACT:
The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
REFERENCES:
patent: 196 38 870 (1998-03-01), None
patent: 100 08 089 (2001-10-01), None
Noren “Myxobacteria . . . ” Myxobacteria . . . CA 52:93347 (1958).
Grever et al. “The national cancer institute . . . ” Seminars in Oncology, v. 19, p. 622-638 (1992).
ATCC catalog information pp. 1-3 (2009).
Beck Barbara
Dömling Alexander
Henkel Bernd
Illgen Katrin
Menon Sanjay
Chang Celia
Corless Peter F.
DiCeglie, Jr. Nicholas J.
Edwards Angell Palmer & & Dodge LLP
R&D-Biopharmaceuticals GmbH
LandOfFree
Tubulysin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tubulysin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tubulysin analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196040